Pharmacy Medical News about Attention Deficit Disorder with Hyperactivity

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Adjunctive Divalproex Versus Placebo for Children With ADHD and Aggression Refractory to Stimulant Monotherapy
American Journal of Psychiatry, 11/06/09

Blader JC et al. – Among children with ADHD whose chronic aggressive behavior is refractory to optimized stimulant treatment, the addition of divalproex increases the likelihood that aggression will remit. A larger trial is necessary to specify with greater precision the magnitude of benefit for adjuvant divalproex.

<< Previous
Antibiotic or bacterial therapy in post-giardiasis irritable...

Next >>
Antitumorigenic effects of cannabinoids beyond apoptosis

Electrocardiographic Screening in Children With Attention-Deficit Hyperactivity Disorder
The American Journal of Cardiology, 10/22/09 Relevance Score: 94%

Comorbidity in Adults With Attention-Deficit Hyperactivity Disorder
Canadian Journal of Psychiatry, 10/20/09 Relevance Score: 94%

Variability of Response Time as a Predictor of Methylphenidate Treatment Response in Korean Children with Attention Deficit Hyperactivity Disorder
Yonsei Medical Journal, 10/29/09 Relevance Score: 93%

Adolescent Girls With Attention-Deficit/Hyperactivity and Borderline Personality Disorders
Clinical Neuropharmacology, 10/12/09 Relevance Score: 93%

Dopaminergic Haplotype as a Predictor of Spatial Inattention in Children With Attention-Deficit/Hyperactivity Disorder
Archives of General Psychiatry, 10/09/09 Relevance Score: 93%